Action BAVARIAN NORDIC A/S
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Communiqués Bavarian Nordic A/S CBOE EUROPE EQUITIES

Actions

DK0015998017

Temps réel estimé Cboe Europe
Autres places de cotation
 16:14:48 05/07/2024
176,4 DKK 0,00 % Graphique intraday de Bavarian Nordic A/S
01/07 Bavarian Nordic transforme sa facilité de 1 milliard de couronnes danoises en un prêt lié au développement durable MT
28/06 Bavarian Nordic fait don d'un vaccin contre la variole pour lutter contre l'épidémie en Afrique MT

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked Loan
GL
Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa
GL
Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya Vaccine Candidate to EMA
GL
Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate
GL
Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine
GL
Bavarian Nordic and CEPI Partners to Advance Mpox Vaccination in Africa
GL
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
GL
Bavarian Nordic A/S : Transactions in Connection with Share Buy Back Program and Termination of Share Buy Back Program
PU
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
GL
EVP and Chief Medical Officer Laurence de Moerlooze Will Be Leaving Bavarian Nordic
GL
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations
GL
Bavarian Nordic A/S : Interim Results (Q1) as of 31 March 2024
PU
Bavarian Nordic Announces Interim Results for the First Three Months of 2024
GL
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
GL
Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve
GL
Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate
GL
ExpreS2ion to receive approximately SEK 22.5 million dividend payment from AdaptVac ApS
AQ
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
GL
Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S
GL
Morris & Dickson is the First U.S. Distributor for Bavarian Nordic's JYNNEOS, the Only FDA-approved Mpox Vaccine
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action BAVA
  4. Action
  5. Actualités Bavarian Nordic A/S
  6. Communiqués